Introduction {#sec0005}
============

With advances in protocols and treatment of cancer patients and consequent increase in survival, the number of patients with bone metastases has increased, as well as the incidence of complications.[@bib0090], [@bib0095], [@bib0100], [@bib0105] One of the complications often found in these patients are pathological fractures, especially in the lower limbs, which invariably affect the meta-epiphyseal region of the bone and requires joint reconstruction. Regarding primary bone tumors, these have also had better outcomes after use of multidrug therapy, resulting in limb salvage possibility; that, in most cases, is only obtained with large bony resections, leading to the need for reconstruction of this bone segment, which in most cases can be attained with non-conventional endoprosthesis.

Metastatic bone disease is the most common bone malignancy,[@bib0090] primarily affecting the axial skeleton, pelvis and femur.[@bib0110], [@bib0115] Metastatic involvement of the lower limbs is associated with a greater number of pathological fractures and promotes increased morbidity / mortality due to prolonged bed rest, increased risk of pneumonia and thromboembolic events.[@bib0115] Under these circumstances, replacement of the bone segment can be attained with an endoprosthesis, which rapidly rehabilitates this patient, who becomes an ambulatory patient.[@bib0090], [@bib0120], [@bib0125], [@bib0130]

Regarding primary bone tumors, osteosarcoma and Ewing\'s sarcoma, as well as giant cell tumors (GCT) of the bone, also occur more often in the lower limbs, with the distal femur and proximal tibia being the preferred locations, affecting the joint region while resulting in the need for joint replacement. As in the upper limbs, these tumors not infrequently affect the proximal humerus.[@bib0095], [@bib0120]

For primary malignant and aggressive benign tumors, a wide resection to achieve necessary safety margin results in large bony resections and, therefore, the need for local reconstruction.[@bib0125], [@bib0135]

Among the techniques based on limb salvage principle, one that has been recommended for treating bone metastases in the lower limbs and the proximal humerus, due to better response and effectiveness, is lesion resection and replacement of the resected segment by an unconventional endoprosthesis,[@bib0110], [@bib0140], [@bib0145] the method of choice in our service.

For malignant primary bone tumors (osteosarcoma, Ewing\'s sarcoma, chondrosarcoma) and aggressive benign tumors (Enneking\'s B3) obtaining a broad or radical margin invariably results in large meta-epiphyseal bone loss, requiring biological or prosthetic reconstruction.[@bib0150] Large bone resections occurring during surgical revisions of conventional arthroplasties are another condition that requires the use of endoprostheses.

In such cases, the biological reconstructions can be performed with autologous bone graft, free or vascularized, homologous graft (tissue bank) or other autograft methods. Although more natural, biological reconstruction shows severe limitations in most cases.[@bib0150]

Prosthetic reconstructions are performed with non-conventional endoprostheses, which replace bones and joints. They are of easy access, provides anatomical reconstruction of the limb, functionally and fast, resulting in early ambulation recovery. However, they also have a high number of complications within short- and long-term follow-up. Postoperative complications of bone tumor resections and replacement of the resected segment by an endoprosthesis are: infection, aseptic implant loosening, periprosthetic fracture, implant fracture and tumor recurrence.[@bib0090], [@bib0120], [@bib0155]

These complications can be responsible for the functional impairment of the affected limb, implant loss and even the amputation of the affected limb.

The purpose of this study is to identify the types of complications found that influenced the average life span of the endoprostheses and function of the operated limb of our patients, according to the functional analysis of the MSTS. These data can be used to improve implant manufacturing and surgical techniques, as the improvement of orthopedic implants and techniques used in bone defect replacement after neoplastic resection is crucial to achieve greater durability, with fewer complications and increased functionality of the operated limb.[@bib0110], [@bib0145], [@bib0150], [@bib0155], [@bib0160]

Material and methods {#sec0010}
====================

This is a retrospective study with 14 patients with malignant and aggressive benign (Enneking\'s B3) tumors, who required reconstructive surgery with non-conventional endoprosthesis. Patients with incomplete medical records that would not allow assessment and those who died or were transferred to another service before completing one year of follow-up were excluded. Patients who did not sign an Informed Consent Form were also excluded.

Mean age of patients was 56 years, with the youngest being 19 and the oldest 66 years of age. Five patients were males and nine were females. As for the tumor site, one (7%) was located in the shoulder, two (14%) in the hip and 11 (78%) in the knee ([Fig. 1](#fig0005){ref-type="fig"}). Considering tumor type, one (7%) was a myeloma, one (7%) an Ewing\'s tumor, three (21%) were bone metastases and six (42%) were chondrosarcomas. All surgeries were performed between 2004 and 2014 ([Fig. 2](#fig0010){ref-type="fig"}). Three patients underwent amputation due to late complications of the endoprosthesis primary procedure. These data are shown in [Table 1](#tbl0005){ref-type="table"}.

Functional assessment was performed according to the classification recommended by Enneking, adopted by the Musculoskeletal Tumor Society (MSTS), whose parameters are mobility, pain, function, emotional acceptance, supports, walking, gait, range of motion (ROM) and strength. Each functional assessment parameter was evaluated with six scoring levels, with the highest score being five and the lowest, zero. Radiographic imaging was also evaluated regarding the endoprosthesis stability, as shown in [Table 2](#tbl0010){ref-type="table"}.

Using the R and Excel software programs, the exploratory data analysis was carried out with 11 patients (three were excluded from the data analysis due to amputation) submitted to endoprosthesis treatment. This work aims to evaluate whether the endoprosthesis is an effective treatment. Using a QQ plot of the mean scores, the assumption of normality of scores was confirmed, that is, as the points are close to the line, the *t*-test can be used to compare the means of the data, as shown in [Table 3](#tbl0015){ref-type="table"} and [Fig. 3](#fig0015){ref-type="fig"}.

Results {#sec0015}
=======

The score value for each patient may vary from eight to 48 and the mean value obtained was 32. Half of the patients who answered the questionnaire had a score between 30 and 36. The lowest observed score was 15 and the highest was 42.

In the overall analysis of the endoprosthesis effectiveness and after establishing that mean scores higher than three is considered a good result and using Student\'s *t*-test (comparison of means) to determine the mean scores, a *p* value = 0.002 was obtained, a statistically significant result.

All variables were also analyzed separately, using the same Student\'s *t* method, considering a response higher than three a satisfactory result. The results ranged from 0.005 *p* to 0.8. Pain, emotional acceptance and strength were statistically significant and showed a *p* value \<0.05. As for function, supports, walking, gait and ROM, they all showed a *p* value \>0.05.

Regarding radiographies, all prostheses were stable, with no apparent signs of loosening or infection, except for the patients who underwent amputation due to postoperative complications or tumor recurrence. All radiographies were performed in the same service.

Discussion {#sec0020}
==========

The current literature is scarce regarding functional results after limb salvage surgery in patients with malignant and aggressive benign tumors, most likely due to the rarity of primary bone tumors. In recent decades, treatment of bone tumors went through changes, since the previously preferred treatment for most cases was amputation. In the beginning of this century, limb salvage surgery became predominant among surgeons, and amputations become only an option, or the treatment of complications after limb salvage surgeries.[@bib0160], [@bib0165]

In a study carried out at Centro Infantil Boldrini published in 2008, authors compared two groups of patients with bone sarcomas in the distal end of the femur, one with total and another with partial endoprostheses, there was no influence on the overall functional outcome and a statistically significant difference was observed only regarding stability.[@bib0170]

In general, non-conventional endoprostheses are excellent devices in the reconstruction of large bone resections; however, they have mechanical limitations, which must be considered before their indication.

This study agrees with the current literature and obtained the same results, showing that the endoprosthesis is an excellent option in the treatment of bone tumors with limb salvage, especially in relation to pain, strength and patient emotional acceptance, according to the results shown in [Table 4](#tbl0020){ref-type="table"}. During the interview, all patients emphasized emotional improvement after surgery, mainly due to pain improvement. Another factor that contributes to the good results demonstrated in this study is the immediate load-bearing capacity, which results in greater patient independence.

However, it is known that the range of motion (ROM) shows limitation in relationship to the contralateral limb, mainly due to loss of muscle mass, either because of age, non-use or resection during surgery. This loss of muscle mass also worsens ambulation capacity and increases the need for assistance during gait. As a consequence of limb deterioration, limb function becomes limited, which again demonstrates the results shown in this study.

Conclusion {#sec0025}
==========

All patients classified the therapy as excellent/good, regardless of the prosthesis type, lesion extension, tumor type and resection performed.

Most patients with bone tumors with limb salvage indication had a life prognosis below that found in the general population, so the early return to everyday activities, independence and ambulation capacity are the treatment goals, making endoprosthesis a viable and effective option for these patients.

Despite the limited study sample, the results obtained from the questionnaire support the current literature. Given the limitation of patients that are adequate for this sample and the fact that it is a current issue, we believe that the endoprosthesis is currently an excellent choice.
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![Preoperative radiographies of one of the study patients, diagnosed with GCT in the left distal femur.](gr1){#fig0005}

![Intraoperative and postoperative radiographic images of the same patient, who was submitted to unconventional modular endoprosthesis of the distal femur with articulated knee.](gr2){#fig0010}

![Q--Q plot of the mean total scores.](gr3){#fig0015}

###### 

Patient data.

Table 1

  Patient   Gender   Age   Surgery   Site       Primary tumor          Amputation
  --------- -------- ----- --------- ---------- ---------------------- ------------
  1         M        41    2004      Knee       GCT                    No
  2         M        52    2008      Hip        Chondrosarcoma         No
  3         F        61    2008      Knee       Chondrosarcoma         Yes
  4         F        66    2008      Knee       Chondrosarcoma         No
  5         M        58    2010      Knee       Chondrosarcoma         Yes
  6         F        81    2011      Knee       Metastasis             No
  7         F        28    2012      Knee       GCT                    No
  8         F        60    2013      Knee       Metastasis -- Breast   No
  9         F        74    2013      Knee       Chondrosarcoma         Yes
  10        M        65    2014      Shoulder   Chondrosarcoma         No
  11        F        56    2014      Hip        Metastasis -- Kidney   No
  12        M        19    2014      Knee       Ewing Sarcoma          No
  13        F        49    2014      Knee       Multiple Myeloma       No
  14        F        31    2014      Knee       GCT                    No

###### 

Questionnaire results.

Table 2

  Patient   Pain   Function   Emotional acceptance   Supports   Walking   Gait   Strength   ROM
  --------- ------ ---------- ---------------------- ---------- --------- ------ ---------- -----
  1         3      5          4                      6          5         4      6          2
  2         6      5          6                      2          4         3      6          5
  3         --     --         --                     --         --        --     --         --
  4         4      4          6                      1          3         2      4          6
  5         --     --         --                     --         --        --     --         --
  6         6      2          6                      2          3         2      6          3
  7         6      5          4                      6          6         4      6          5
  8         6      2          6                      1          2         2      6          6
  9         --     --         --                     --         --        --     --         --
  10        4      1          4                      6          --        --     0          0
  11        4      3          5                      1          3         2      6          4
  12        5      5          4                      6          5         5      6          4
  13        4      3          2                      3          4         3      6          5
  14        3      3          6                      6          6         2      6          2

###### 

Mean of total scores of questions per patient.

Table 3

  Patient   Mean of scores
  --------- ----------------
  1         4.375
  2         4.625
  4         3.75
  6         3.75
  7         5.25
  8         3.875
  10        1.875
  11        3.5
  12        5
  13        3.75
  14        4.25

###### 

Results of tests, their efficacy and respective *p*-value.

Table 4

  Results of the mean comparison test         
  ------------------------------------- ----- -------
  Pain                                  Yes   0.001
  Function                              No    0.150
  Emotional acceptance                  Yes   0.005
  Supports                              No    0.200
  Walking                               No    0.100
  Gait                                  No    0.800
  Strength                              Yes   0.001
  ROM                                   No    0.090
  Total                                 Yes   0.002
